SCHEMBL18155083

SCHEMBL18155083

O=c1[nH]cc(-c2cc(F)c(CO)c(F)c2)cc1-c1nc2cc(N3CCNCC3)ccc2[nH]1

nearest known ligand 0.64

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
TGFB2 P61812 1/20 0.64
PARP1 P09874 1/20 0.39
MET P08581 1/20 0.38
RPS6KA3 P51812 1/20 0.38
ATR Q13535 1/20 0.35
FGFR1 P11362 4/20 0.35
PDGFRB P09619 3/20 0.35
KDR P35968 3/20 0.35
ACVR1 Q04771 1/20 0.35
PIM1 P11309 4/20 0.34
PIM3 Q86V86 4/20 0.34
FLT3 P36888 2/20 0.34
KCNH2 Q12809 1/20 0.34
CDC7 O00311 1/20 0.33
IDO1 P14902 1/20 0.33
TDO2 P48775 1/20 0.33
IDO2 Q6ZQW0 1/20 0.33
PIM2 Q9P1W9 1/20 0.33
HDAC3 O15379 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18155053 0.90 TGFB2 (0.64) TGFB2PARP1METRPS6KA3ATR
SCHEMBL18155060 0.88 TGFB2 (0.64) TGFB2PARP1METRPS6KA3ATR
SCHEMBL18155032 0.86 TGFB2 (0.72) TGFB2PARP1METKDRACVR1
SCHEMBL18155087 0.85 TGFB2 (0.61) TGFB2PARP1METRPS6KA3PIM1
SCHEMBL18155029 0.85 TGFB2 (0.87) TGFB2PARP1FGFR1PDGFRBKDR
Trifluoroacetic Acid SCHEMBL18155112 0.85 TGFB2 (0.58) TGFB2PARP1METRPS6KA3ATR
Hydrochloric Acid SCHEMBL18155058 0.84 TGFB2 (0.85) TGFB2PARP1FGFR1PDGFRBKDR
SCHEMBL18155059 0.84 TGFB2 (0.63) TGFB2PARP1METRPS6KA3ATR
SCHEMBL18155108 0.82 TGFB2 (0.81) TGFB2PARP1PIM1PIM3FLT3
SCHEMBL18155047 0.82 TGFB2 (0.65) TGFB2PARP1METACVR1PIM1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3283475-B1 3-(1H-BENZIMIDAZOL-2-YL)-1H-PYRIDIN-2-ONE DERIVATIVES MERCK PATENT GMBH (DE) 2019-10-16 EP claimed
EP-3283475-A1 3-(1H-BENZIMIDAZOL-2-YL)-1H-PYRIDIN-2-ONE DERIVATIVES Merck Patent GmbH (DE) 2018-02-21 EP claimed
WO-2016165808-A1 3-(1H-BENZIMIDAZOL-2-YL)-1H-PYRIDIN-2-ONE DERIVATIVES MERCK PATENT GMBH (DE) 2016-10-20 WO claimed
EP-3283475-B1 3-(1H-BENZIMIDAZOL-2-YL)-1H-PYRIDIN-2-ONE DERIVATIVES MERCK PATENT GMBH (DE) 2019-10-16 EP disclosed
US-10179777-B2 3-(1H-benzimidazol-2-yl)-1H-pyridin-2-one derivatives MERCK PATENT GMBH (DE) 2019-01-15 US disclosed
US-20180099947-A1 3-(1H-BENZIMIDAZOL-2-YL)-1H-PYRIDIN-2-ONE DERIVATIVES MERCK PATENT GMBH (DE) 2018-04-12 US disclosed
EP-3283475-A1 3-(1H-BENZIMIDAZOL-2-YL)-1H-PYRIDIN-2-ONE DERIVATIVES Merck Patent GmbH (DE) 2018-02-21 EP disclosed
WO-2016165808-A1 3-(1H-BENZIMIDAZOL-2-YL)-1H-PYRIDIN-2-ONE DERIVATIVES MERCK PATENT GMBH (DE) 2016-10-20 WO disclosed
WO-2016165808-A1 3-(1H-BENZIMIDAZOL-2-YL)-1H-PYRIDIN-2-ONE DERIVATIVES MERCK PATENT GMBH (DE) 2016-10-20 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10179777-B2 3-(1H-benzimidazol-2-yl)-1H-pyridin-2-one derivatives ALK, ABL2, ACVR1 TGFB2 267/4885PARP1 518/4885MET 1112/4885
US-20180099947-A1 3-(1H-BENZIMIDAZOL-2-YL)-1H-PYRIDIN-2-ONE DERIVATIVES ALK, ABL2, ACVR1 TGFB2 267/4885PARP1 518/4885MET 1112/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.